Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice

Neuroscience Letters

Volumn 368, Issue 3, 2004, Pages 285-289

  Tucker, H Michael ^a   Simpson, James ^a   Kihiko Ehmann, Muthoni ^a   Younkin, Linda H ^b   McGillis, Joseph P ^c   Younkin, Steven G ^b   Degen, Jay L ^d   Estus, Steven ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Alzheimers disease; Amyloid; Plasmin; Proteolysis

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN PROTEIN; PLASMIN; PLASMINOGEN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STEADY STATE;

AMYLOID BETA-PROTEIN; ANIMALS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PLASMIN; PLASMINOGEN;

EID: 4544260590     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.07.011     Document Type: Article

References (26)

1. T.H. Bugge, K.W. Kombrinck, M.J. Flick, C.C. Daugherty, M.J. Danton, and J.L. Degen Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency Cell 87 1996 709 719
2. J.L. Degen, A.F. Drew, J.S. Palumbo, K.W. Kombrinck, J.A. Bezerra, M.J. Danton, K. Holmback, and T.T. Suh Genetic manipulation of fibrinogen and fibrinolysis in mice Ann. N.Y. Acad. Sci. 936 2001 276 290
3. A.F. Drew, H.L. Tucker, K.W. Kombrinck, D.I. Simon, T.H. Bugge, and J.L. Degen Plasminogen is a critical determinant of vascular remodeling in mice Circ. Res. 87 2000 133 139
4. T. Dyrks, E. Dyrks, C.L. Masters, and K. Beyreuther Amyloidogenicity of rodent and human beta A4 sequences FEBS Lett. 324 1993 231 236
5. E.A. Eckman, D.K. Reed, and C.B. Eckman Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme J. Biol. Chem. 276 2001 24540 24548
6. E.A. Eckman, M. Watson, L. Marlow, K. Sambamurti, and C.B. Eckman Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme J. Biol. Chem. 278 2003 2081 2084
7. N. Ertekin-Taner, N. Graff-Radford, L.H. Younkin, C. Eckman, M. Baker, J. Adamson, J. Ronald, J. Blangero, M. Hutton, and S.G. Younkin Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees Science 290 2000 2303 2304
8. C. Exley, and O.V. Korchazhkina Plasmin cleaves Abeta42 in vitro and prevents its aggregation into beta-pleated sheet structures Neuroreport 12 2001 2967 2970
9. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, M.P. Frosch, C.B. Eckman, R.E. Tanzi, D.J. Selkoe, and S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc. Natl. Acad. Sci. USA 100 2003 4162 4167
10. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P. Gerard, C. Gerard, E. Hama, H.J. Lee, and T.C. Saido Metabolic regulation of brain Abeta by neprilysin Science 292 2001 1550 1552
11. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H.J. Lee, E. Hama, Y. Sekine-Aizawa, and T.C. Saido Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nat. Med. 6 2000 143 150
12. T. Kawarabayashi, L. Younkin, T. Saido, M. Shoji, K. Ashe, and S. Younkin Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease J. Neurosci. 21 2001 372 381
13. I.V. Kurochkin, and S. Goto Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Lett. 345 1994 33 37
14. J.R. McDermott, and A.M. Gibson Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme Neurochem. Res. 22 1997 49 56
15. J.P. Melchor, R. Pawlak, and S. Strickland The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration J. Neurosci. 23 2003 8867 8871
16. B.C. Miller, E.A. Eckman, K. Sambamurti, N. Dobbs, K.M. Chow, C.B. Eckman, L.B. Hersh, and D.L. Thiele Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proc. Natl. Acad. Sci. USA 100 2003 6221 6226
17. V.A. Ploplis, P. Carmeliet, S. Vazirzadeh, I. Van Vlaenderen, L. Moons, E.F. Plow, and D. Collen Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice Circulation 92 1995 2585 2593
18. J.F. Pohl, H. Melin-Aldana, G. Sabla, J.L. Degen, and J.A. Bezerra Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury Am. J. Pathol. 159 2001 2179 2186
19. G.W. Rebeck, S.D. Harr, D.K. Strickland, and B.T. Hyman Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein Ann. Neurol. 37 1995 211 217
20. J. Romer, T.H. Bugge, C. Pyke, L.R. Lund, M.J. Flick, J.L. Degen, and K. Dano Impaired wound healing in mice with a disrupted plasminogen gene Nat. Med. 2 1996 287 292
21. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, and S.G. Younkin Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat. Med. 2 1995 864 870
22. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
23. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180
24. D.J. Selkoe Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease J. Clin. Invest. 110 2002 1375 1381
25. H.M. Tucker, M.E. Kihiko, J.N. Caldwell, S. Wright, T. Kawarabayashi, D. Price, S. Scheff, J.P. McGillis, R.E. Rydel, and S. Estus Amyloid-beta activates and is degraded by the plasmin system J. Neurosci. 20 2000 3937 3946
26. W.E. Van Nostrand, and M. Porter Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity Biochemistry 38 1999 11570 11576